GO:0090733 tenascin complex: Components and Research

The tenascin complex (GO:0090733) is an extracellular matrix assembly defined in QuickGO as a homotrimeric or homohexameric complex involved in cell adhesion and cell migration. In mammals, four distinct complexes are recognized: Tenascin-C, Tenascin-N (also known as Tenascin-W), Tenascin-X and Tenascin-R. These large, multi-domain glycoproteins are not merely structural scaffolds; they act as microenvironmental signals that modulate how cells attach, move and respond to injury. Because the term is a cellular_component, it describes where these complexes reside and how they are built rather than a single enzymatic activity. Researchers study GO:0090733 to understand how extracellular matrix composition controls cell behavior in development, immunity and repair. Tenascin-C, the archetypal member, is dynamically expressed during infection and inflammation, where it influences immune cell recruitment and cytokine responses. Its pathogenic potential is illustrated by studies showing that Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy and that exosomal Tenascin-C primes macrophage pyroptosis, amplifying aberrant inflammation during sepsis-induced acute lung injury. Beyond inflammation, single-cell and spatial transcriptomics have identified proinflammatory and profibrotic niches after kidney injury in which matrix components such as tenascin family members contribute to the injury microenvironment. These findings position the tenascin complex as a central node linking extracellular matrix remodeling to disease progression. Finally, clinical translation is emerging: a common extracellular matrix fragmentation pattern, including tenascin complex fragments, has been detected in patient plasma and proposed as a potential biomarker for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Together, these studies justify sustained research into the assembly, regulation and disease roles of GO:0090733.

In our own words, GO:0090733 tenascin complex refers to a secreted extracellular matrix complex that is either a homotrimer or a homohexamer and functions in cell adhesion and cell migration. The term covers four mammalian complexes: Tenascin-C, Tenascin-N (also called Tenascin-W), Tenascin-X and Tenascin-R. Each complex is built from one type of tenascin subunit, giving the complex its homomeric character, and each is deposited in the extracellular matrix where it interacts with cell-surface receptors and other matrix molecules to influence adhesion and motility.

The tenascin complex is important because it sits at the interface between cells and their extracellular environment, controlling adhesion and migration programs that are essential for tissue development, immune responses and repair. Dysregulation of tenascin complex components is increasingly linked to human disease: Tenascin-C drives cardiovascular dysfunction in diabetic cardiomyopathy, exosomal Tenascin-C amplifies inflammation in sepsis-induced acute lung injury, and tenascin-rich proinflammatory and profibrotic niches form after kidney injury. In addition, extracellular matrix fragmentation patterns involving tenascin complex proteins can be measured in patient plasma and may help diagnose hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Because the complex is extracellular and modular, it is also a tractable target for biomarker and therapeutic research, and CRISPR models allow causal testing of each family member.

The tenascin complex is encoded by a small family of large extracellular matrix genes whose protein products form the four mammalian complexes.

Regulation of the tenascin complex occurs primarily at the level of gene expression and extracellular proteolysis. Tenascin-C is dynamically induced during infection and inflammation, indicating that its expression is controlled by inflammatory signals in the tissue microenvironment. In sepsis-induced acute lung injury, exosomal Tenascin-C primes macrophage pyroptosis, showing that the complex can be packaged and delivered to immune cells to amplify inflammation. After kidney injury, single-cell and spatial transcriptomics reveal that tenascin family components are part of a proinflammatory and profibrotic niche, suggesting regulation by injury-associated transcriptional programs. In diabetic cardiomyopathy, Tenascin-C drives cardiovascular dysfunction, implying that metabolic stress pathways regulate its expression or activity in the heart. Finally, proteolytic fragmentation of tenascin complex proteins generates plasma fragments that can be measured as biomarkers, indicating that extracellular proteases regulate the complex post-translationally.

Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy. This study demonstrates that the tenascin complex is not only a marker of cardiac stress but an active contributor to myocardial dysfunction in metabolic heart disease. The findings support investigating tenascin complex components as therapeutic targets in diabetic cardiomyopathy.

A virological view of tenascin-C in infection highlights its induction and functional roles during host-pathogen interactions. In sepsis-induced acute lung injury, exosomal Tenascin-C primes macrophage pyroptosis, amplifying aberrant inflammation. These studies link the tenascin complex to both protective and pathological immune responses, making it a key node in infection-associated tissue injury.

Single-cell and spatial transcriptomics define a proinflammatory and profibrotic niche after kidney injury in which tenascin family components contribute to the injury microenvironment. This positions the tenascin complex as a driver of the transition from acute kidney injury to chronic fibrosis, with potential as a target for antifibrotic intervention.

Evidence of a common extracellular matrix fragmentation pattern in patient plasma, including tenascin complex fragments, has been proposed as a potential biomarker for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. This suggests that tenascin complex proteolysis reflects connective tissue pathology and could aid diagnosis of these under-recognized disorders.

Single-cell and spatial transcriptomics can map which cells express tenascin complex genes and where the complexes localize within injured tissues. This approach defined a proinflammatory and profibrotic niche after kidney injury in which tenascin family components are part of the injury microenvironment. It is ideal for discovering cell-type-specific regulation of the tenascin complex.

Exosomal Tenascin-C primes macrophage pyroptosis in sepsis-induced acute lung injury. Exosome isolation combined with macrophage pyroptosis assays allows researchers to test whether tenascin complex components carried in extracellular vesicles are functionally active. This method bridges extracellular matrix biology and intercellular signaling.

A common extracellular matrix fragmentation pattern, including tenascin complex fragments, has been detected in patient plasma and proposed as a potential biomarker for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Mass spectrometry or immunoassays targeting tenascin fragments can be used to quantify these biomarkers in clinical samples.

Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy. Echocardiography, hemodynamic measurements and histology in knockout or overexpression models can determine whether tenascin complex components causally affect cardiac function. These methods are essential for translational cardiovascular research.

Researchers studying tenascin complex-related genes often need to determine whether a candidate gene is causally involved in extracellular matrix biology, inflammation or fibrosis. EDITGENE provides CRISPR-based cell models and screening services that enable precise manipulation of tenascin complex genes in relevant cellular contexts.

The tenascin complex (GO:0090733) is a defined extracellular matrix assembly with four mammalian members that control cell adhesion and migration. Its best-characterized subunit, Tenascin-C, is increasingly recognized as a driver of cardiovascular dysfunction, infection-associated inflammation, sepsis-induced lung injury and kidney fibrosis. Fragments of tenascin complex proteins in plasma also hold promise as biomarkers for connective tissue disorders. CRISPR-based models and advanced transcriptomic methods provide the tools needed to dissect these mechanisms and translate them into therapeutic and diagnostic advances.